Essential phospholipids as a supportive adjunct in the management of patients with NAFLD
Arab Journal of Gastroenterology. 2015; 16 (3-4): 99-104
in English
| IMEMR
| ID: emr-174961
ABSTRACT
Background and study aims:
Treatment of nonalcoholic fatty liver [NAFLD] is important because NAFLD patients have a 1.7-fold increase in standardised age and gender matched mortality. Currently treatment is based on life style modification and managing comorbid associating disease. Other medications remain experimental. Essential phospholipid [EPL] is a nutrient for the liver, helping to maintain vitality of cell membranes where the vast majority of liver activities are regulated. We performed a randomised open label study to evaluate EPL as an adjuvant nutrient to the treatment of primary NAFLD or NAFLD with comorbid disease
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Phosphatidylcholines
/
Phospholipids
/
Prospective Studies
/
Disease Management
/
Transaminases
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
English
Journal:
Arab J. Gastroenterol.
Year:
2015
Similar
MEDLINE
...
LILACS
LIS